Position in PAHC
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$188
-$641 QoQ
Shares Held
6
-60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#196
of 206 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $375,029,634 across 23 Drug Manufacturers - Specialty & Generic names. PAHC ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
624,068 | $338,138,764 | |
| 2 | ZTS |
Zoetis Inc.
|
282,029 | $20,266,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
314,687 | $5,044,432 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
16,414 | $2,766,415 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
81,250 | $2,752,750 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
49,713 | $2,312,151 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
68,590 | $1,384,146 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
12,110 | $1,343,483 |
All Filings in PAHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188 | 6 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $829 | 15 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $224 | 6 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||